Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 17 studies | 51% ± 19% | |
| glutamatergic neuron | 6 studies | 39% ± 19% | |
| GABAergic neuron | 6 studies | 33% ± 18% | |
| oligodendrocyte precursor cell | 4 studies | 21% ± 5% | |
| neuron | 3 studies | 34% ± 14% | |
| endothelial cell | 3 studies | 22% ± 8% | |
| astrocyte | 3 studies | 22% ± 5% | |
| type I pneumocyte | 3 studies | 20% ± 1% | |
| interneuron | 3 studies | 38% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 11 studies | 36% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 13074.65 | 2626 / 2642 | 97% | 24.41 | 684 / 705 |
| pancreas | 95% | 2619.14 | 313 / 328 | 83% | 5.47 | 148 / 178 |
| lung | 87% | 2757.23 | 500 / 578 | 55% | 3.27 | 631 / 1155 |
| esophagus | 52% | 1655.40 | 748 / 1445 | 69% | 4.79 | 126 / 183 |
| intestine | 62% | 2535.15 | 597 / 966 | 56% | 3.58 | 297 / 527 |
| prostate | 40% | 1070.53 | 99 / 245 | 71% | 2.85 | 355 / 502 |
| stomach | 45% | 1008.11 | 161 / 359 | 64% | 4.81 | 182 / 286 |
| spleen | 99% | 3731.46 | 239 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 12% | 228.90 | 32 / 258 | 78% | 9.70 | 180 / 230 |
| thymus | 35% | 647.48 | 230 / 653 | 52% | 2.26 | 315 / 605 |
| eye | 0% | 0 | 0 / 0 | 85% | 4.58 | 68 / 80 |
| skin | 2% | 33.23 | 32 / 1809 | 72% | 7.45 | 342 / 472 |
| peripheral blood | 73% | 5906.43 | 682 / 929 | 0% | 0 | 0 / 0 |
| breast | 10% | 258.66 | 47 / 459 | 37% | 1.62 | 411 / 1118 |
| ovary | 2% | 37.27 | 3 / 180 | 43% | 2.11 | 186 / 430 |
| uterus | 4% | 73.49 | 7 / 170 | 31% | 1.62 | 144 / 459 |
| bladder | 5% | 183.95 | 1 / 21 | 28% | 1.39 | 141 / 504 |
| kidney | 0% | 0 | 0 / 89 | 23% | 0.80 | 207 / 901 |
| liver | 1% | 18.34 | 2 / 226 | 16% | 0.89 | 66 / 406 |
| adipose | 12% | 410.09 | 142 / 1204 | 0% | 0 | 0 / 0 |
| heart | 11% | 196.54 | 94 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 9% | 344.36 | 118 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.14 | 3 / 45 |
| muscle | 0% | 3.43 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007420 | Biological process | brain development |
| GO_0038083 | Biological process | peptidyl-tyrosine autophosphorylation |
| GO_0008150 | Biological process | biological_process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0016020 | Cellular component | membrane |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0004713 | Molecular function | protein tyrosine kinase activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | AATK |
| Protein name | Apoptosis associated tyrosine kinase Serine/threonine-protein kinase LMTK1 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase) (AATYK) (Brain apoptosis-associated tyrosine kinase) (CDK5-binding protein) (Lemur tyrosine kinase 1) (p35-binding protein) (p35BP) |
| Synonyms | LMR1 LMTK1 AATYK KIAA0641 |
| Description | FUNCTION: May be involved in neuronal differentiation. . |
| Accessions | H7C175 ENST00000576053.1 ENST00000417379.6 ENST00000374792.6 [Q6ZMQ8-3] ENST00000570932.5 A0A3B3ISC2 ENST00000572339.5 A0A3B3ISA0 I3L461 ENST00000650574.1 Q6ZMQ8 A0A3B3ISX0 ENST00000326724.9 [Q6ZMQ8-1] ENST00000575363.1 I3L360 |
